Pancreatic beta-cell mass in European subjects with type 2 diabetes.
about
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumorsAn Update on the Effect of Incretin-Based Therapies on β-Cell Function and MassDynamic pathology of islet endocrine cells in type 2 diabetes: β-Cell growth, death, regeneration and their clinical implicationsEarly Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementRole of microRNAs in islet beta-cell compensation and failure during diabetesConcise review: in search of unlimited sources of functional human pancreatic beta cellsConcise review: pancreas regeneration: recent advances and perspectivesType 2 diabetes: etiology and reversibilityDoes disruption of circadian rhythms contribute to beta-cell failure in type 2 diabetes?The Beta Cell in Its Cluster: Stochastic Graphs of Beta Cell Connectivity in the Islets of Langerhansβ-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.Natural history of β-cell adaptation and failure in type 2 diabetesAlogliptin benzoate for management of type 2 diabetesClass II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cellsImaging in pancreatic disease.Monitoring C-Peptide Storage and Secretion in Islet β-Cells In Vitro and In Vivo.Adult tissue sources for new β cells.Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery.Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy.Chromosomal mapping of pancreatic islet morphological features and regulatory hormones in the spontaneously diabetic (Type 2) Goto-Kakizaki ratPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue.β-cell mass in people with type 2 diabetes.β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.Pancreatic β-cell proliferation in obesity.Targeting β-cell functions in therapy for type 2 diabetes.Progressive deterioration of insulin secretion in Japanese type 2 diabetic patients in comparison with those who carry the S20G mutation of the islet amyloid polypeptide gene: A long-term follow-up studyUtility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetesβ-Cell failure in type 2 diabetes.Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic controlAge-associated changes of islet endocrine cells and the effects of body mass index in Japanese.Research Resource: A Dual Proteomic Approach Identifies Regulated Islet Proteins During β-Cell Mass Expansion In Vivo.MicroRNA-7a regulates pancreatic β cell function.Automated assessment of β-cell area and density per islet and patient using TMEM27 and BACE2 immunofluorescence staining in human pancreatic β-cells.Current status of islet cell replacement and regeneration therapy.Increased circulating betatrophin concentrations in patients with type 2 diabetes.Estimation of insulin secretion, glucose uptake by tissues, and liver handling of glucose using a mathematical model of glucose-insulin homeostasis in lean and obese mice.
P2860
Q24598747-7DD6D5E2-E2B5-4134-9432-AF1EBF7C93F8Q26749089-FECC25E9-FF39-4F4C-8BBD-8818750A3501Q26752746-1B15FA37-D83E-4DE7-9F80-F70519AE36B5Q26767164-A2F57AB3-DE3E-475B-8E03-0DFB96EA7F07Q26769878-B916AAA1-46C3-4444-922E-C00C3C961001Q26995308-8B2ED469-2C3F-43F6-9A20-A28BF496B6A9Q26999928-3667154E-8DB1-4FFD-A61C-376B3E1C6C2AQ27013646-73A976D8-22DA-4C32-8843-6190B87FD8D3Q27016644-F562351F-1D18-465D-98F0-C3D62C20961AQ27026480-EC3C221A-65CA-40FE-916C-16FA49F49C67Q27318143-A92812B5-D1CB-4653-8F88-9D34D828B90EQ27692665-F28F2980-5F7F-45F4-A9DB-4E9608480A3BQ28082002-6A6DA004-F847-47DF-B8E1-0CF8C74C1ECCQ28083933-9FC38CC8-11EF-4475-A356-475AB1D132E2Q28575171-7F3C18E2-FE91-43C9-A0C8-BF12E9A20861Q30275458-12346057-57FF-41E4-837A-6911981AE91EQ30277941-960C5812-1705-45A7-BD17-92C4645C981DQ30356946-1A73E195-78E8-425B-B7D6-738338C2B6F4Q30360570-82F2E8E0-4211-41BE-918B-7DD27D88BCACQ30496377-777B33C3-CC41-4605-A1B9-83BF65FA3525Q30497268-53D2D16B-446C-4FEE-BE19-87194972F9FFQ30597265-861026C6-5A5D-45AA-85F8-77C473D83F6BQ30903914-35F5D681-7CB5-4FFE-8280-B048EE411581Q31103663-811758A8-CEF4-41B3-8E63-1E68BF8C186BQ33558395-38D88BFC-BD76-40F9-ABDB-476BC0FA4CE2Q33570085-2406C96B-9E41-4CB1-AD7B-711493DA3347Q33578671-63C76478-95F8-450C-AA00-3E69AB75E804Q33585610-F664ACFF-6B2F-4118-96A4-34B97E158269Q33585856-2BE9302B-C30C-4807-8DD8-8C3AF9250B74Q33585873-E1707846-DEA6-4A7E-AA11-68A72F95F918Q33588325-28195A8A-E0D1-4226-85C2-93093E6CAD33Q33607736-497D2044-78CE-415D-9EC6-19F724A0B587Q33610661-BD7CB806-4E07-4962-A659-00A6AE381E0EQ33628658-972C0901-C80D-4865-A1B6-C9B4A0175299Q33631454-ED8BA81F-20F5-40EE-AE96-E00736CE74B3Q33685948-0691FC85-8FA3-4984-B6E4-82BCF6A55372Q33721502-7EE0C898-A686-46D6-993E-FDDC1A63B452Q33738705-BA3BB1AA-AC61-4212-949E-1A1C49E8F670Q33746462-F55AE40C-8681-41D5-80CB-DF484231F5F2Q33774989-7DCDB033-7844-4CE9-96C2-61D6E4A37300
P2860
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@en
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@nl
type
label
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@en
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@nl
prefLabel
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@en
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@nl
P2093
P1476
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
@en
P2093
P356
10.1111/J.1463-1326.2008.00969.X
P478
10 Suppl 4
P577
2008-11-01T00:00:00Z